Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Take to the Courts
April 12, 2012
from Marketwired News Releases
Watson's Generic VANCOCIN® HCl Capsules Receive FDA Approval
April 10, 2012
from PR Newswire
Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
April 03, 2012
from PR Newswire
Watson Confirms LUMIGAN(R) and LATISSE(R) Patent Challenges
April 03, 2012
- Paragraph IV Litigations Underway - Read More
from PR Newswire
Critical Stock Alerts: Citigroup, Microsoft, Baker Hughes, Watson, Zynga, and Assured Guaranty
March 22, 2012
from PR Newswire
Watson's Generic BONIVA® 150mg Receives FDA Approval
March 20, 2012
from PR Newswire
Watson Confirms NIASPAN(R) Patent Challenge
March 19, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Confirms BYSTOLIC(R) Patent Challenge
March 14, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Announces Initiation of Esmya(R) U.S. Phase 3 Clinical Trial
March 12, 2012
- Trial Underway for Women with Uterine Fibroids - Read More
from PR Newswire
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Continue to Capitalize on Expiring Patents
March 12, 2012
from Marketwired News Releases
Columbia Laboratories Reports Fourth Quarter and Year-End 2011 Financial Results
March 08, 2012
from Business Wire News Releases
Watson Launches Generic PROMETRIUM(R)
March 02, 2012
from PR Newswire
Watson to Present at the Barclays Capital 2012 Global Healthcare Conference
March 01, 2012
from PR Newswire
Columbia Laboratories Announces 42% Workforce Reduction
March 01, 2012
from Business Wire News Releases
Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
February 27, 2012
from PR Newswire
Watson to Present at the 2012 RBC Capital Markets' Healthcare Conference
February 22, 2012
from PR Newswire
Watson to Present at the Citi 2012 Global Healthcare Conference
February 16, 2012
from PR Newswire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results
February 16, 2012
from Business Wire News Releases
Critical Alerts for priceline.com, Tesoro, Weatherford International, Tata Motors, and Watson Pharmaceutical Released by Seven Summits Research
February 15, 2012
from PR Newswire
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
February 14, 2012
- Full Year 2011 Non-GAAP EPS Increases 39% To $4.77; GAAP EPS $2.06 - Read More
from PR Newswire
Columbia Laboratories Transfers NDA for Progesterone Vaginal Gel 8% to Watson Pharmaceuticals
February 13, 2012
from PR Newswire
Watson Confirms Beyaz(R) Patent Challenge
February 10, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Reaches Settlement With Janssen Pharmaceuticals, Inc. Over ORTHO TRI-CYCLEN(R) LO
February 08, 2012
from PR Newswire
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES®
February 06, 2012
from Business Wire News Releases
Watson Provides Update on Generic Lidoderm® Application
February 03, 2012
from PR Newswire
Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2011 Earnings
January 30, 2012
from PR Newswire
Watson Announces New Jersey-Based Global R&D Technology Center
January 30, 2012
- New Facility to Support Generic Pharmaceutical Product Development; Employ Approximately 50 Scientists, Chemists, Engineers, and Support Staff - Read More
from PR Newswire
Watson Reaches Settlement with Mallinckrodt Over Exalgo(R)
January 26, 2012
from PR Newswire
Watson Confirms Court Stays Preliminary Injunction
January 26, 2012
- Permits Launch of Generic LOVENOX® - Read More
from PR Newswire
Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
January 24, 2012
- Preliminary Net Revenues Climb Approximately 28% to Approximately $4.57 Billion - Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here